Larimar Therapeutics Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio

HCCC Stock

Larimar Therapeutics Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $13.68 on 02/15/24, while the lowest value for the same period was recorded at $2.18 on 11/10/23.

52-week price history of LRMR Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Larimar Therapeutics Inc’s current trading price is -35.27% away from its 52-week high, while its distance from the 52-week low is 306.19%. The stock’s price range during the 52-week period has remained between $2.18 and $13.68. In the Healthcare sector, the company’s shares saw a trading volume of around 1.44 million for the day, which was evidently higher than the average daily volume of 0.53 million over the past three months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Market Capitalization and Financial Performance: An In-Depth Look

Larimar Therapeutics Inc (LRMR) has experienced a quarterly rise of 22.65% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 564.95M and boasts a workforce of 42 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 8.46, with a change in price of +0.11. Similarly, Larimar Therapeutics Inc recorded 638,044 in trading volume during the last 100 days, posting a change of +1.32%.

Examining LRMR’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for LRMR stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.

LRMR Stock Stochastic Average

As of today, Larimar Therapeutics Inc’s raw stochastic average for the last 50 days stands at 65.60%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 60.44%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 41.52% and 31.68%, respectively.

LRMR Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price increase of 94.62%. However, over the past six months, we’ve seen a weaker performance of 89.21%. The price of LRMR leaped by -6.79% over the last 30 days. And in the last five days, it has surged by 7.46%.

Most Popular